Primrose Bio's Prima RNApols™ ExTend Named Among The Top RNA Polymerases For mRNA Synthesis In Independent University Of British Columbia Study

“In our down-selection RNA polymerase comparison study, Prima RNApols™ ExTend demonstrated an attractive balance of IVT performance, maintaining yield and RNA integrity while minimizing dsRNA byproducts.”
— Andrew Varley; Director, UBC RNA Formulation Core (RFC), University of British Columbia (UBC)*

_{*As a nonprofit, independent third‑party facility, the RFC is committed to providing unbiased benchmarking and validation}

In an independent RNA polymerase comparison conducted by UBC, Prima RNApols™ ExTend, enzyme number 13 in the study, was named among the top performers for mRNA synthesis based on a balanced profile of competitive IVT yield and integrity with best-in-set dsRNA minimization.

By outperforming the industry-standard T7, Primrose Bio's Prima RNApols improve the cost and quality profiles of pharmaceutical mRNA manufacturing. Prima RNApols perform across formats (linear, self-amplifying, circular) and a range of DNA template lengths, while remaining compatible with various capping chemistries, modified nucleotides, and IVT conditions.

For more information, visit primrosebio.com